PURPOSE: To measure prevalence, incidence, and correlates of chlamydia and gonorrhea among injection drug users (IDUs). METHODS: Participants (n = 2129; 63% male, 52% white, ages 18-30 years) in five US cities were tested for chlamydia and gonorrhea by urine LCR assay and completed a standardized questionnaire about demographics and recent sexual behavior. Logistic regression identified correlates of prevalent infection; incidence rates were calculated from 6-month follow-up data. RESULTS: Chlamydia prevalence was 5.2% and did not differ by gender. Gonorrhea prevalence was 0.2% among men and 2.0% among women, P < .001. Among men, younger age [OR (95% CI): 0.89 (0.83-0.96)], age at sexual debut [0.91 (0.83-0.99)], and African American race [2.92 (1.53-5.59)] were associated with chlamydia. Among women, age at sexual debut [1.16 (1.02-1.31)] and commercial sex [1.96 (1.03-3.74)] were associated with chlamydia, and with gonorrhea [1.27 (1.04-1.56)] and [5.17 (1.66-16.11)], respectively. At 6 months, the cumulative incidence of chlamydia was 1.7% among men and 4.4% among women, P = .03; no men and 1.3% of women tested positive for gonorrhea, P = .01. IMPLICATIONS: Prevalence and correlates of chlamydia and gonorrhea were similar to other samples, suggesting that screening criteria need not be modified for IDU populations. The number of behavioral correlates identified was limited; perhaps unmeasured sexual-network-level factors play a role in determining sexually transmitted disease (STD) prevalence.
PURPOSE: To measure prevalence, incidence, and correlates of chlamydia and gonorrhea among injection drug users (IDUs). METHODS:Participants (n = 2129; 63% male, 52% white, ages 18-30 years) in five US cities were tested for chlamydia and gonorrhea by urine LCR assay and completed a standardized questionnaire about demographics and recent sexual behavior. Logistic regression identified correlates of prevalent infection; incidence rates were calculated from 6-month follow-up data. RESULTS: Chlamydia prevalence was 5.2% and did not differ by gender. Gonorrhea prevalence was 0.2% among men and 2.0% among women, P < .001. Among men, younger age [OR (95% CI): 0.89 (0.83-0.96)], age at sexual debut [0.91 (0.83-0.99)], and African American race [2.92 (1.53-5.59)] were associated with chlamydia. Among women, age at sexual debut [1.16 (1.02-1.31)] and commercial sex [1.96 (1.03-3.74)] were associated with chlamydia, and with gonorrhea [1.27 (1.04-1.56)] and [5.17 (1.66-16.11)], respectively. At 6 months, the cumulative incidence of chlamydia was 1.7% among men and 4.4% among women, P = .03; no men and 1.3% of women tested positive for gonorrhea, P = .01. IMPLICATIONS: Prevalence and correlates of chlamydia and gonorrhea were similar to other samples, suggesting that screening criteria need not be modified for IDU populations. The number of behavioral correlates identified was limited; perhaps unmeasured sexual-network-level factors play a role in determining sexually transmitted disease (STD) prevalence.
Authors: Samuel R Friedman; Danielle C Ompad; Carey Maslow; Rebecca Young; Patricia Case; Sharon M Hudson; Theresa Diaz; Edward Morse; Susan Bailey; Don C Des Jarlais; Theresa Perlis; Amber Hollibaugh; Richard S Garfein Journal: Am J Public Health Date: 2003-06 Impact factor: 9.308
Authors: Marilyn M Metzler; Donna L Higgins; Carolyn G Beeker; Nicholas Freudenberg; Paula M Lantz; Kirsten D Senturia; Alison A Eisinger; Edna A Viruell-Fuentes; Bookda Gheisar; Ann-Gel Palermo; Donald Softley Journal: Am J Public Health Date: 2003-05 Impact factor: 9.308
Authors: Martina Morris; Mark S Handcock; William C Miller; Carol A Ford; John L Schmitz; Marcia M Hobbs; Myron S Cohen; Kathleen M Harris; J Richard Udry Journal: Am J Public Health Date: 2006-05-02 Impact factor: 9.308
Authors: Sudip Chatterjee; Barbara Tempalski; Enrique R Pouget; Hannah L F Cooper; Charles M Cleland; Samuel R Friedman Journal: AIDS Behav Date: 2011-10
Authors: Danielle C Ompad; Robin M Ikeda; Nina Shah; Crystal M Fuller; Susan Bailey; Edward Morse; Peter Kerndt; Carey Maslow; Yingfeng Wu; David Vlahov; Richard Garfein; Steffanie A Strathdee Journal: Am J Public Health Date: 2005-04 Impact factor: 9.308
Authors: Courtenay E Cavanaugh; Leah J Floyd; Typhanye V Penniman; Alicia Hulbert; Charlotte Gaydos; William W Latimer Journal: J Womens Health (Larchmt) Date: 2011-02 Impact factor: 2.681
Authors: Laura M Kuyper; Courtney Lc Collins; Thomas Kerr; Robert S Hogg; Kathy Li; Mark W Tyndall; Julio Sg Montaner; Evan Wood Journal: Can J Infect Dis Med Microbiol Date: 2005-07 Impact factor: 2.471